T2D susceptibility mutations in the SLC16A11 coding region produce gain-of-function mutant proteins, resulting in the upregulation of hepatic Lipin1 protein expression and an abnormal accumulation of lipid droplets, ultimately contributing to the onset of T2D (Zhao et al., 2019b). This evidence concerns the gene SLC16A11 and type 2 diabetes mellitus.